Noveris Health Sciences is trading 14.29% up at CA$0.08 on October 2, 2026, with no confirmed company-specific catalyst identified.
- No October 2 company announcement appears in its news listings; the latest listed release is dated September 9.
- The move cannot be clearly tied to broader sentiment: Reuters reported Canadian index futures up 0.2% ahead of U.S. jobs data, while the provided market context points to stronger U.S. indices.
- No direct catalyst or evidence linking the move to the market was found, so the reason remains unclear.